Alzheimer’s disease and a long-standing exposure to glucose in the Western diet

 

Chronic exposure to glucose due to the traditional Western diet impairs neuronal function and causes apoptosis (programmed neuronal death), concluded Drs Seneff & Wainwright (UK) and Mascitelli (Italy). Their reasoning was roughly the following:

The amyloid-beta peptide (AB) in Alzheimer’s disease (AD) plaques so far seen as a hallmark of this disease, in fact may be an early attempt of protection from its development.  AB switches neuronal metabolism from glycolysis-based to the use of other substrates, e.g., lactate and ketone bodies. This is a very important adjustment in the AD case since there’s an insulin resistance in the AD brain indicating an inadequate ability to utilize glucose. Moreover, the levels of advanced glycation end-products (harmful in any case) are increased in AD. The damage they induce interferes with delivery of fats and cholesterol to astrocytes, and consequently to neurons. This is important because for smooth communication between neurons, sufficient levels of fat and cholesterol is required and the AD CSF is deficient in both. Synthesis of AB is increased when lipid supply is deficient. In the condition of this deficiency, there’s an increase in synthesis of excitatory neurotransmitter glutamate leading to oxidative damage and toxic overexcitability.

The good news is, wrote the authors, a simple dietary change towards lower carbohydrate intake and higher fats intake, may be efficiently protective against AD.

Source:

European Journal of Internal Medicine 22 (2011) 134–140

Glucose versus lactate in immature brain slices

Related Q&A: Y Ben-Ari writes that ‘Zilberter and Bregestovski and colleagues’ dealt with ‘ketone body metabolites’. What does ketone body metabolite mean? ”

About this post

1. These quotes were first used by Elly Strammer at F1000.com. After she agreed to remove her post from there, she contacted us suggesting that we use the quotes. We thank Elly for her contribution and for further commenting at the Naturally Selected

2. We received many questions regarding this post, quite a few of them concerned the formatting, which was not helping to clearly understand the issue. Because of that, we updated the post making sure to visually indicate quotes belonging to the arguing sides (according to F1000.comNow, remarks related to comments concerning the works of Y. Zilberter et al. are marked as  and remarks by Y. Ben-Ari are marked as 

 ”We demonstrate that in the neonatal brain, Em [membrane potential] and EGABA [reversal potential of GABA-induced anionic currents] strongly depend on composition of the energy substrate pool. Complementing glucose with ketone bodies, pyruvate or lactate resulted in a significant hyperpolarization of both Em and EGABA, and induced a radical shift in the mode of GABAergic synaptic transmission towards network inhibition.” (1)

“The main conclusions of our work are that the inhibitory effect of L-lactate on GDPs is not mediated by mitochondrial energy metabolism, and that glucose at its standard 10 mM concentration is an adequate energy substrate for neonatal neurons in vitro.” (2)

 ”We show that in the presence of glucose, lactate is effectively utilized as an energy substrate, causing an augmentation of oxidative metabolism. Moreover, in the absence of glucose lactate is fully capable of maintaining synaptic function. Therefore, during network activity in neonatal slices, lactate can be an efficient energy substrate capable of sustaining and enhancing aerobic energy metabolism.” (3)

“Lactate is not an efficient replacement for glucose and, as in vivo glucose is always kept at 4-5mM in the brain even in conditions of severe stress.” (4 a)

“The fact is, in the extracellular fluid (ECF) in the brain, glucose concentration is between 1.9 mM and 0.59 while lactate concentration is between 5.1 mM and 0.78 mM (for review, see [9 in this post]). The question arises: why 10 mM glucose in standard ACSF is adequate but 10 mM lactate is not.” (5)

“Clearly, the suggestions of Zilberter and colleagues rely on wrong assumptions and results that have not been reproduced.” (4 a)

“The effect of weak acids on GABA reversal potential and GDP generation was initially described for 4-5 mM concentrations of BHB [ketone body beta-hydroxybutyrate] (Rheims et al. 2009 ), lactate and pyruvate (Holmgren et al. 2010), and was later confirmed by independent research groups for similar concentrations of pyruvate (Tyzio et al. 2011), lactate and propionate (Ruusuvuori et al. 2010).” (6)

“From a clinical perspective, it is interesting to stress that relying on their observations on the positive actions of lactate on metabolism, Zilberter and colleagues have suggested that administration of lactate may be “a novel therapeutic tool to cure Parkinson, Alzheimer, Leigh syndrome and epilepsies” (4a)

 From Brain Fuels: This quotation is taken out of context. The exact piece from (9) reads: “… a growing body of evidence shows that metabolic stress caused by impaired energy homeostasis is a common feature of neurodegenerative disorders (NDDs) such as Alzheimer disease, Leigh syndrome, epilepsy, dementia, multiple sclerosis, neuropathies or ataxias [88] and [89]. We speculate that endogenous ES such as lactate, BHB and pyruvate or their combinations can be efficient in treatingNDD, and would address the cause rather than symptoms. Indeed, the neuroprotective effects of pyruvate have been repeatedly demonstrated in cases of brain ischemia, hypoglycemia, hemorragia, stroke and kainate-inducedepileptic brain damage[90], [91], [92]and [93]. Further research into mechanisms of the effects of ES on fundamental neuronal properties might allow more rapid progress in preventing and managing NDDs.

The comment made on 29 Jul 2011 (4 b) quoted this paragraph with the references removed thus attributing the text solely to (9).

“Considering the compelling and well-known clinical observation that high lactate level is a classical sign of neuron suffering and severe conditions that require rapid intervention, this suggestion is, to say the least, astonishing.” (4 a)

“The bulk of the evidence suggests that lactate is an important intermediary in numerous metabolic processes, a particularly mobile fuel for aerobic metabolism, and perhaps a mediator of redox state among various compartments both within and between cells. Lactate can no longer be considered the usual suspect for metabolic ‘crimes’, but is instead a central player in cellular, regional and whole body metabolism… we might term the period from the 1930s to approximately the early 1970s the dead-end waste product era.” (7)

” It is curious that Dr Zilberter and colleagues refer to metabolism but have never reported measuring it.” (4 b)

“…Ivanov et al. (2011) simultaneously recorded oxygen tension, NAD(P)H fluorescence transients and local field potentials during electrical stimulation of the hippocampal Schaffer collateral pathway in neonatal brain tissue slices from mice. From the very beginning, the authors took great care to ensure both viability and functionality of their preparations. They convincingly demonstrated that surprisingly high superfusion rates with standard artificial cerebrospinal fluid (ACSF) in the slice chamber are required to ensure adequate oxygenation and complete electrical function in blood-free tissue slices. An important implication of this methodological tour de force is that under many previously reported experiments the requirements for viability may been met while the functionality may have been compromised.” (8)

References

  1. Holmgren, C. D., Mukhtarov, M., Malkov, A. E., Popova, I. Y., Bregestovski, P., and Zilberter, Y. (2010). Energy substrate availability as a determinant of neuronal resting potential, GABA signaling and spontaneous network activity in the neonatal cortex in vitro. J. Neurochem. 112, 900–912.
  2. Ruusuvuori E et al. (2010). Spontaneous network events driven by depolarizing GABA action in neonatal hippocampal slices are not attributable to deficient mitochondrial energy metabolism. J Neurosci. Nov 17; 30(46):15638-42
  3. Ivanov A, Mukhtarov M, Bregestovski P and Zilberter Y (2011) Lactate effectively covers energy demands during neuronal network activity in neonatal hippocampal slices. Front. Neuroenerg. 3:2.
  4. Ben-Ari Y.  a) Faculty of 1000, 06 Jan 2011, evaluation,  b) 29 Jul 2011, comment.
  5. Zilberter Y. Faculty of 1000, 19 May 2011 and July 14 2011, comments.
  6. Khakhalin A (May 18, 2011). Questioning the depolarizing effects of GABA during early brain development. J Neurophysiol doi: 0.1152/jn.00293.2011.
  7. Mendel I. Faculty of 1000, 04 Jun 2011, comment (Currently the comment is removed).
  8. Kasischke K (2011) Lactate fuels the neonatal brain. Front. Neuroenerg. 3:4. doi: 10.3389/fnene.2011.00004
  9. Zilberter Y, Zilberter T, Bregestovski P. (2010) Neuronal activity in vitro and the in vivo reality: the role of energy homeostasis. Trends PharmacolSci 31:394–401.

What can be done to fight off Alzheimer’s disease?

Q&A and FAQ (archived) :: Ongoing Q&A :: Neuroscience Q&A and FAQ

Question
I’ve read on WebMD that there’s no evidence that anything can be done to fight off Alzheimer’s disease. But I also read the opposite opinions. What is yours? – Donna

Answer
Dear Donna,

You probably mean the following conclusion cited by WebMD:

“There is currently no evidence considered to be of even moderate scientific quality supporting the association of any modifiable factor (nutritional supplements, herbal preparations, dietary factors, prescription or nonprescription drugs, social or economic factors, medical conditions, toxins, environmental exposures) with reduced risk of Alzheimer’s disease,” concludes the report, issued by a National Institutes of Health consensus panel on Alzheimer’s prevention.”

I am surprised that they haven’t mentioned exercise, for which, in my humble opinion, a solid body of evidence exists and the caffein research, for which intricate mechanisms are being researched. Also, quite a few harmful influences such as hydrogen peroxide, glutamate, zinc, and copper/cysteine were convincingly reported. I added caffein effects on another neurodegenerative disease, the Parkinson’s but I know of similar studies in Alzheimer’s.

Walking away from dementia

Coffee, tea, and chocolate can help to avoid Parkinson’s disease

Pyruvate protects neurons against A-beta peptides characteristic for Alzheimer’s
Tanya Zilberter

Neuroprotective effects of Coenzyme Q10

Related: Is Q10 a fitness-enhancing or an anti-aging supplement in the long run?

“Several clinical trials of CoQ10 have been performed in Parkinson’s disease and atypical Parkinson’s syndromes, Huntington’s disease, Alzheimer disease, Friedreich’s ataxia, and amyotrophic lateral sclerosis, with equivocal findings. CoQ10 is widely available in multiple formulations and is very well tolerated with minimal adverse effects, making it an attractive potential therapy.”
Meredith Spindler, M Flint Beal, and Claire Henchcliffe. Coenzyme Q10 effects in neurodegenerative disease. Neuropsychiatr Dis Treat. 2009; 5: 597–610
“There is ample evidence showing involvement of mitochondrial dysfunction in the pathogenesis of neurodegenerative disorders, therefore, one would predict that agents that alleviate mitochondrial dysfunction could be beneficial and exert neuroprotective effects. Several bioenergetic agents that improve mitochondrial function including creatine, coenzyme Q10 (CoQ10), nicotinamide, riboflavin and lipoic acid are being tested for their neuroprotective efficacy in neurodegenerative disorders. Among them, creatine and CoQ10 are in clinical trials for PD, HD and AD.”
Rajnish K. Chaturvedi and M. Flint Beal. Mitochondrial approaches for neuroprotection. Ann N Y Acad Sci. 2008 December; 1147: 395–412
“…combination therapy using CoQ10 and creatine may be useful in the treatment of neurodegenerative diseases such as Parkinson’s disease and HD.”
Lichuan Yang  et al., Combination therapy with Coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson’s and Huntington’s Diseases. J Neurochemistry, 109, 5, 1427–1439, 2009
“…a synthetic analog of CoQ10, idebenone, has been investigated in clinical trials for its ability to inhibit lipid peroxidation. Although several smaller studies reported beneficial effects on memory and attention after several months of treatment, a larger study reported no effect in slowing disease progression.”
Magali Dumont, M. Flint Beal. Neuroprotective strategies involving ROS in Alzheimer disease. Free Radical Biology and Medicine, 2011, online ahead of print
“These data demonstrate that in addition to reducing intracellular deposition of A-beta, CoQ10 can also reduce plaque pathology. Our study further supports the use
of CoQ10 as a therapeutic candidate for AD.”
Xifei Yang et al., Coenzyme Q10 Reduces β-Amyloid Plaque in an APP/PS1
Transgenic Mouse Model of Alzheimer’s Disease. Mol Neurosci (2010) 41:110–113
Abbreviations

PD: Parkinson’s disease;
HD: Huntington’s disease;
AD: Alzheimer’s disease;
A-beta – beta-Amyloid peptide

Brain and iodine deficiency in children and adults

Related:

Food sources of iodine

Selected nutrients in foods

Iodine plays an important role in the synthesis of thyroid hormones, which regulate the metabolic processes in the brain. Iodine deficiency affecting thyroid hormones during this critical periods of brain development result in hypothyroidism and brain damage. Iodine consumption in the geographic locations known to be deficient areas can be below those needed for the brain normal development and both children and adults in these areas can be at risk of brain disorders and mental retardation (Thyroid 2000;10:871–87).

In Toscani, in 6–10 year old children with mild iodine deficiency (64 micrograms/day), the slowing of reaction in movement tasks was observed (Endocrinol Invest 1995;18:57–62) as well as low visual-motor performances, motor skill and perception. These children had low development quotients and IQ (Iodine and the brain. New York: Plenum Press, 1989: 1–379). The IQ in otherwise normal children deficient in iodine is shifted towards low values (Bull World Health Organ 1986;64:547–51; J Nutr, 1999;129:980–7).

Severe endemic iodine deficiency such as in New Guinea, China, Indonesia, and Thailand causes the clinical picture of cretinism with dominant neurological pathologies (Thyroid 1993;3:59–69; Eur J Endocrinol 1997;137:349–55). It has been shown experimentally that the most detrimental is the combination of iodine and selenium deficiencies. In the rat fetuses in such condition, experiments showed the developmental failure of the central nervous system (Nutritional factors involved in the goitrogenic action of cassava. Ottawa: International Development Research Centre, 1982: 74–83).

“Endemic cretinism is now included in the spectrum of the effects of iodine deficiency in a population termed the ‘iodine deficiency disorders (IDDs)’, which also includes a wide range of lesser degrees of cognitive defect that can be prevented by the correction of iodine deficiency. Iodine deficiency is now recognised by the World Health Organization (WHO) as the most common preventable cause of brain damage with in excess of 2 billion at risk from 130 countries.” — Z-P. Chen & B.S. Hetzel (2010). Cretinism revisited. Best Practice & Research Clinical Endocrinology & Metabolism, 24:1, 39-50

The eight mechanisms of anti-Alzheimer’s effects of curcumin

Related: Resveratrol and curcumin, plant’s own weapons that protect the brain

1. Curcumin is a better antioxidant than alpha-tocopherol and can protect blood vessel cells from oxidative stress caused by Amyloid beta peptide (Abeta), the main constituent of amyloid plaques in the brains of Alzheimer’s disease (AD) patients. Interestingly, with low-dose curcumin, but not with high-dose curcumin the plaque occurrence was decreased by up to 50%.

2. Curcumin significantly lowered levels of oxidized proteins, which content is elevated in the brains of mice model of AD.

3. Curcumin inhibits the formation of fibrillar Abeta (fAbeta) and destabilized already formed fAbeta.

4. In animal models of AD, curcumin prevented cognitive deficits presumably by binding the redox-active metals Fe and Cu.

5. Curcumin decreased Abeta formation. When fed to aged mice with advanced amyloid accumulation, curcumin directly binds small beta-amyloid and blocks fibril formation.

6. Beta-amyloid peptide can form a peroxidase playing a major role in the pathologies of AD. Curcumin inhibits this peroxidase.

7. Curcumin enhances the phagocytosis and Abeta removal by macrophages, the process that is impaired in patients with AD.

8. Curcumin crosses the blood–brain barrier, disrupts existing plaques and partially restores damaged neurones in annimal AD model leading to a significant reversal of structural neuronal damage.

Source

B.B. Aggarwal, K.B. Harikumar. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. The International Journal of Biochemistry & Cell Biology 41 (2009) 40–59

Music is good for the brain

The study conducted by researchers at McGill University in Montreal and published in January 2011 issue of Nature Neuroscience showed that the music increased dopamine levels in certain areas of the brain. Various types of music were shown to be effective depending on individual preferences. (1). On the other hand, dopamine is crucial in the brain system of movement organization, deficiencies of brain cells producing dopamine, as we know, result in Parkinson’s disease, and the only reliable method of treatment is the L-DOPA medication having severe side effects and gradually losing its efficiency as the disease progresses.

Other studies revealed that music (e.g., exposure to Mozart’s music) can decrease the blood pressure in hypertensive patients and even experimental animals. Increased dopamine levels improve dopaminergic neurotransmission in epilepsy (2), dementia (3), and ADHD (4).

The beneficial effects of music are thought to work through brain structures involved in reward processing including the nucleus accumbens* and the ventral tegmental area**, hypothalamus*** and insula****

Sources

1. Music – it does a body and mind good, Baxterbulletin.com

2. Brain Res. Rev. 25 (1997), pp. 1–26

3. Exp. Aging Res., Volume 27, Issue 3 July 2001 , pp. 215 – 228

4. J. Learn. Disabil. 29 (1996), pp. 238–246

Footnotes

* also known as “center of motivation”

** a component of the reward pathway in the brain

*** a very important brain area responsible for many bodily functions as well as instincts for basic survival, fight or flight, mating, eating, and drinking, etc.

**** linked to emotions, perception, motor control, self-awareness, cognitive functioning, and interpersonal experience.

Complex Regional Pain Syndrome (CRPS) and vegan diet

Original Q&A :: About these Q&A :: Other Q&A

QUESTION: Hi Tanya,

I was wondering whether there are any studies that show a link between diet and CRPS. In particular, could a switch to being vegan cause an imbalance of any kind that could contribute to the onset of CRPS? Not immediately, of course, but over a period of many months.

I looked up how neurons & nerves work (http://en.wikipedia.org/wiki/Neuron) and saw that its basically an electrical system activated by calcium, sodium, chloride, etc. This made me wonder if imbalances in those elements could upset the nervous system but I don’t know enough about how it all works to tell.

In the case of a vegan I’m thinking the imbalance could be a deficiency in calcium. Another factor (not necessarily vegan) could be an excess of salt in the diet causing an imbalance of sodium and chlorides.

ANSWER: Hi Simon,

As far as I’m concerned, the short answer to your main question is negative. What’s more, many people suffering from CRPS claim improvement in their condition after they switch to the vegan diet.

As to the Na, Ca, Cl, etc. imbalances you are asking about, they keep being balanced back to possible normal condition due to the intricate work of multilevel homeostasis long after the CRPS symptoms are developed so CRPS is considered a localaixed rather than systemic condition – this is why it’s called “regional”.

MDs are not sure what causes CRPS but think that they are either mechanical (trauma, spasms, bone deformation, etc.) or autoimmune, or are due to the sympathetic nervous system disfunction. As you can see, nutritional deficiencies are not among recognized causes.

On the other hand, you might want to know health consequences of long-term vegan way of eating. Vegans consume less saturated fat and cholesterol and more dietary fiber so they usually have lower cholesterol, and lower blood pressure, and risk of heart disease. However, they have an increased increases risk of  vitamins B-12 and D, calcium, omega-3 fatty acids, iron and zinc.

Tanya Zilberter

———- FOLLOW-UP ———-

QUESTION: Hi Tanya,

Thanks for the prompt response!

So I get the point that my question simplifies a complex process and that body does some self-correcting to ensure that things are all OK. However, if existing sufferers notice an improvement when they change their diet, it still seems like diet could contribute to the onset of the condition. Is it possible that (whether or not its about being vegan) being more attentive to their diet changed the quality/balance of what they ate, causing the improvement?

ANSWER: Most certainly. However, it’s not clear how this particular diet works to influence your condition. In other cases, for example, of the ketogenic diet, there is the growing body of evidence that it has neuroprotective effects (in conditions such as epilepsy, Alzheimer’s, Parkinson’s, and many others) because:

1. It supplies the nervous system with an energy substrate that is different from glucose and in most of the neurodegenerative diseases, on of the major metabolic problem is insulin insensitivity and/or other causes of inability to metabolize glucose, thus metabolic crisis.

2. In many cases of inflammation,  excessive glucose processing, glycolysis, contributes to the process via generation of reactive oxygen species (ROS). Also, during non-stop glycolysis, the process of glycation takes place making two of intermediaries of glycolysis  became toxins, while when glycolysis goes on in a moderate pace, they can be even neuroprotective.

However, as you are a vegan,it’s all not your case. I suspect that the vegan diet finally does a very similar thing, but due to the inevitable calorie restriction, which can most probably be due to very low energy density of your daily meals — and calorie restriction is strongly neuroprotective.

You might want to read more about it at:

How can calorie restriction improve brain function?

The seven effects of ketone bodies making them powerful neuroprotectors

Toxic glycolysis and brain aging


Memory impairment, hippocampal atrophy, and the 10,000 steps a day rule.

Twenty-five percent of individuals over 65 years of age have sufficient cognitive problems, short of dementia, to affect the quality of their lives (1, 2). The ability to learn consciously and recall new information, which is known as recent or declarative memory, is one of the areas most affected during aging. However, our knowledge about the medical factors that predispose a person to age-associated cognitive problems remains undeveloped.

After the age of 65, a quarter of otherwise normal, healthy people have memory problems serious enough to affect their quality of life. Learning and memorizing new information is the most prominent cognitive deficit in these people. Is there anything that can be done to prevent and/or to improve this condition?

First, it’s important to know what changes in elderly people’s brain and metabolism and how these changes are different in the 25% of those having poorer memories and those that retain robust learning and memory capacity.

  • They have glucose intolerance
  • Their brain region responsible for new memory processing, hippocampus, shrinks according to MRI
  • The delivery of metabolic substrates to the hippocampus is compromised

What can be done?

There are at least two things that should be kept in mind:

1. The 10,000 steps a day does work. In one study, at the background level, participants made average 5,000 steps a day. During the experiment, they were instructed to increase their daily walking (cumulative) to 10,000 steps — and after 4 weeks, not only their glucose tolerance improved, but their blood pressure normalized.

2. Get enough sleep. Reduced sleep duration is associated with glucose intolerance especially when combined with physical inactivity and overeating.

More on brain aging and NDD prevention at Ageless Brain (click to read)

Sources

Unverzagt F et. al., Neurology. 2001;57:1655–1662.

Convit A et. al., Proc Natl Acad Sci USA, 2003, v.100(4); Feb 18

Swartz A et. al., Prev Med. 2003 Oct;37(4):356-62

Nedeltcheva A et al., J Clinical Endocrinology & Metabolism 2009, Vol. 94, No. 9 3242-3250

The MMM of aging: mood, memory, movement

“Thinking, Moving, Feeling”: What Do They Have in Common?

This question opens a review of age-related declines, their inter-relationships, mechanisms, and the ways to postpone if not avoid them. The authors discuss the occurrence of depression and mood disorders during normal, premature or pathological aging, reminding that the usual suspects – serotonin and norepinephrine – indeed decline as people age as well as in Alzheimer’s and Parkinson’s diseases (A, Granholm et al., Mood, Memory and Movement: An Age-Related Neurodegenerative Complex? Curr Aging Sci. 2008 July ; 1(2): 133–139.)

(more…)

Older Posts » To leave a comment or question click here